Acadian Asset Management
PTX

Acadian Asset Management’s Pernix Therapeutics Holdings, Inc. PTX Stock Holding History

Acadian Asset Management’s Portfolio PTX Stock Details PTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-19,805
Closed -$89K – 1662
2016
Q2 		$89K Sell
19,805
-36,949
-65% -$241K ﹤0.01% 1055
2016
Q1 		$595K Buy
56,754
+23,933
+73% +$476K ﹤0.01% 720
2015
Q4 		$968K Buy
+32,821
New +$992K 0.01% 697

Other funds holding PTX

Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
AC
Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.26% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
GC
Globeflex Capital San Diego, California $661M AUM 50.59% 1-Year Est. Return
JG
Jefferies Group New York $12B AUM 6.2% 1-Year Est. Return

Acadian Asset Management's PTX Position: Q3 2016 in Review

Acadian Asset Management sold out of Pernix Therapeutics Holdings, Inc. (PTX) in Q3 2016, closing a stake of 19,805 shares — an estimated $89K sold.

Acadian Asset Management first reported a position in PTX in Q4 2015 and held it in 3 quarters. The position peaked at $968K in Q4 2015. 48 funds tracked by Wall St. Rank hold PTX as of Q3 2016.

  • Acadian Asset Management reported no remaining Pernix Therapeutics Holdings, Inc. position as of Q3 2016 after selling out during the quarter.
  • Acadian Asset Management sold 19,805 Pernix Therapeutics Holdings, Inc. shares in Q3 2016, an estimated $89K.
  • Acadian Asset Management first reported a position in Pernix Therapeutics Holdings, Inc. in Q4 2015 and held it in 3 quarters.
  • Acadian Asset Management's Pernix Therapeutics Holdings, Inc. position peaked at $968K in Q4 2015.
  • 48 funds tracked by Wall St. Rank held Pernix Therapeutics Holdings, Inc. as of Q3 2016.

Based on Acadian Asset Management's 13F filing for Q3 2016, filed 20 Oct 2016.